Page last updated: 2024-09-05

sorafenib and rhamnetin

sorafenib has been researched along with rhamnetin in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(rhamnetin)
Trials
(rhamnetin)
Recent Studies (post-2010) (rhamnetin)
6,5207305,25180049

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)rhamnetin (IC50)
Aldo-keto reductase family 1 member B1Homo sapiens (human)2.7
ELAV-like protein 3Homo sapiens (human)1.2
Inositol hexakisphosphate kinase 2Homo sapiens (human)1.8

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cao, Y; Feng, F; Hou, MX; Jia, H; Jiang, QY; Ma, HD; Sun, HW; Wang, T; Yang, Q; Yang, YP1
Cao, S; Feng, F; Jia, H; Jiang, Q; Li, B; Lu, J; Wei, L; Zhang, Y1

Other Studies

2 other study(ies) available for sorafenib and rhamnetin

ArticleYear
Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Biochimica et biophysica acta, 2016, Volume: 1860, Issue:7

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Male; Mice, SCID; MicroRNAs; Niacinamide; Paclitaxel; Phenylurea Compounds; Protein Kinase Inhibitors; Quercetin; Receptor, Notch1; Signal Transduction; Sorafenib; Transfection; Xenograft Model Antitumor Assays

2016
Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis.
    Food & function, 2021, Mar-21, Volume: 12, Issue:6

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Interactions; Drug Resistance, Neoplasm; Liver; Liver Neoplasms; Mice; Mice, Nude; MicroRNAs; Pregnane X Receptor; Quercetin; Sorafenib

2021